Cisapride Tablets and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Cisapride Tablets and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cisapride
Brand name: Propulsid
Synonyms: n.a.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisapride Tablets-Insulin glulisine
- Cisapride Tablets-Insulin Glulisine (Cartridges and Pens)
- Cisapride Tablets-Insulin Glulisine (Vials)
- Cisapride Tablets-Insulin glulisine Subcutaneous
- Cisapride Tablets-Insulin human inhaled Inhalation
- Cisapride Tablets-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Cisatracurium
- Insulin glargine, recombinant Subcutaneous-Cisatracurium Besylate
- Insulin glargine, recombinant Subcutaneous-Cisatracurium Besylate Injection
- Insulin glargine, recombinant Subcutaneous-Cisatracurium besylate Intravenous
- Insulin glargine, recombinant Subcutaneous-Cisplatin
- Insulin glargine, recombinant Subcutaneous-Cisplatin Intravenous